Are there differences in ME/CFS rates between those who had COVID-19 vs those who did not have COVID-19?

Study by Dr. Joann Elmore examines myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-like illness in both populations

COVID-19
By Elmore Research Group
1 min read

A study led by UCLA and other study sites finds that the rates of individuals identified with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-like illness were similar between people with and without COVID-19.

Read the UCLA Health News article 

Read the JAMA Network Open article 

Citation: Unger ER, Lin JS, Wisk LE, Yu H, L'Hommedieu M, Lavretsky H, Montoy JCC, Gottlieb MA, Rising KL, Gentile NL, Santangelo M, Venkatesh AK, Rodriguez RM, Hill MJ, Geyer RE, Kean ER, Saydah S, McDonald SA, Huebinger R, Idris AH, Dorney J, Hota B, Spatz ES, Stephens KA, Weinstein RA, Elmore JG; Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After SARS-CoV-2 Infection. JAMA Netw Open. 2024 Jul 1;7(7):e2423555. doi: 10.1001/jamanetworkopen.2024.23555. PMID: 39046739; PMCID: PMC11270135.